Načítá se...
Molecular mechanisms of statin intolerance
Statins reduce cardiovascular morbidity and mortality in primary and secondary prevention. Despite their efficacy, many persons are unable to tolerate statins due to adverse events such as hepatotoxicity and myalgia/myopathy. In the case of most patients, it seems that mild-to-moderate abnormalities...
Uloženo v:
| Vydáno v: | Arch Med Sci |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Termedia Publishing House
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4889699/ https://ncbi.nlm.nih.gov/pubmed/27279860 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/aoms.2016.59938 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|